Aimmune Therapeutics (AIMT)
Chart for AIMT
Over the next 13 weeks, Aimmune Therapeutics has on average historically fallen by 11.5% based on the past 2 years of stock performance.
Aimmune Therapeutics has fallen lower by an average 11.5% in 2 of those 2 years over the subsequent 13 week period,corresponding to a historical probability of 100%
The holding period that leads to the greatest annualized return for Aimmune Therapeutics, based on historical prices, is 2 weeks. Should Aimmune Therapeutics stock move in the future similarly to its average historical movement over this duration, an annualized return of 157% could result.
